Skip to main content
. 2023 Aug 5;12(15):2005. doi: 10.3390/cells12152005

Figure 1.

Figure 1

Effects of SR-1 long-term treatment on the expression of surface markers in EPCs. (A) Schematic representation to show isolation of EPCs from the human umbilical cord blood and ex vivo expansion with SR-1 treatment for experiment. (B) Expression of EPC surface marker (CD34, c-kit, CXCR4, VEGFR-2, CD144) was measured using flow cytometry analysis of young and senescent cells with continuous treatment of SR-1. (SR-1 1 μM treatment).